Anatomical Pathology QAP
-
ALK Translocation for non-small cell lung carcinoma (NSCLC)
-
Breast Diagnostic
-
Dermatopathology Diagnostic
-
Electron Microscopy Diagnostic
-
Paediatric Diagnostic
-
Forensic Diagnostic
-
Gastrointestinal Diagnostic
-
Neuropathology Diagnostic
-
Gynaecology Diagnostic
-
Haematopathology Diagnostic
-
Head and Neck Diagnostic
-
Fluorescence in-situ Hybridisation (FISH) Diagnostic
Biosecurity QAP
-
Bacterial Specimen Module
-
Biopreparedness Exercise – Bacteria
-
Emerging Biological Threats – Molecular
-
Emerging Biological Threats – Serology
-
Environmental Specimen Module
-
SSBA eLearning Module – Anthrax
-
SSBA eLearning Module – Botulism
-
SSBA eLearning Module – Ebola
-
SSBA eLearning Module – History of Biowarfare/Bioterrorism SSBA eLearning Module – Plague
-
SSBA eLearning Module – Smallpox
-
SSBA eLearning Module – Toxins
-
SSBA eLearning Module – Tularemia
-
Viral Specimen Module
-
Whole Genome Sequencing Module
-
Blood Borne VirusesHepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
-
Enteric Viruses and BacteriaClostridium difficile EHEC Norovirus Rotavirus
-
Human Adenovirus, Human Herpesvirus and PolyomavirusHuman adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
-
Respiratory Viruses, Bacteria and FungiHuman adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
-
Tropical and other Viruses, Bacteria and ParasitesAHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
The RCPAQAP Anatomical Pathology discipline offers programs in the areas of diagnostic and technical proficiency of histopathology laboratories. Diagnostic survey cases are selected to demonstrate either classical histological features of a disease process, common disease processes observed in routine pathology laboratories or critical disease processes of educational value to participants. The diagnostic proficiency programs offer enrolments for laboratories, individual pathologists and trainees.
-
Blood Borne VirusesHepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
-
Enteric Viruses and BacteriaClostridium difficile EHEC Norovirus Rotavirus
-
Human Adenovirus, Human Herpesvirus and PolyomavirusHuman adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
-
Respiratory Viruses, Bacteria and FungiHuman adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
-
Tropical and other Viruses, Bacteria and ParasitesAHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
In 2008 the Australian Government established a two-tiered list of Security Sensitive Biological Agents (SSBA) as part of the SSBA Regulatory Scheme for the control of select agents and toxins. Funding was subsequently made available through the Department of Health to establish RCPAQAP Biosecurity, with the aim of providing a quality assurance and proficiency testing program (PTP) for Tier 1 and Tier 2 SSBA, other potential agents and communicable disease threats. The program now offers surveys free of charge to Australian laboratories and for a fee to approved overseas laboratories with a view to building and enhancing laboratory capacity and capability to detect, analyze, identify and report on these agents.
Chemical Pathology QAP
-
Alcohol and Ammonia
-
B Natriuretic Peptide (BNP)
-
Blood Gases: CO-oximetry
-
C Reactive Protein
-
Condensed PoCT: Troponin
-
CSF: Oligoclonal Bands
-
Dried Blood Spot
-
Endocrine
-
Faecal Occult Blood
-
General Urine Chemistry
-
HbA1c: Whole Blood
-
Neonatal Bilirubin
-
Porphyrins: Plasma
-
Salivary Cortisol
-
Special Drugs
-
Serum Indices
-
Special Lipids
-
Sweat Testing
-
Toxicology Screening: On-Site Urine
-
Trace Elements: Whole Blood
-
Tumour Markers
-
Urine Pregnancy
-
Vitamin C
-
Vitamins: Serum
Cytopathology QAP
-
Gynaecological
-
Non-Gynaecological
-
Performance Measures
-
Technical
-
Gynaecological
-
Conventional
-
Liquid based SurePath
-
Liquid based ThinPrep
-
Non-Gynaecological
-
General
-
Fine Needle Aspiration
-
Specialty
-
Performance Measures
-
Technical
-
Blood Borne VirusesHepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
-
Enteric Viruses and BacteriaClostridium difficile EHEC Norovirus Rotavirus
-
Human Adenovirus, Human Herpesvirus and PolyomavirusHuman adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
-
Respiratory Viruses, Bacteria and FungiHuman adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
-
Tropical and other Viruses, Bacteria and ParasitesAHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
The RCPAQAP Chemical Pathology discipline programs are run in association with the Australasian Association of Clinical Biochemists (AACB) whose members provide expertise and assistance via specialized Advisory Committees. All Chemical Pathology Full Programs are made up of data management and a complete set of material containing all the samples to be analyzed for the full enrolment year is distributed to participants following enrolment.
-
Blood Borne VirusesHepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
-
Enteric Viruses and BacteriaClostridium difficile EHEC Norovirus Rotavirus
-
Human Adenovirus, Human Herpesvirus and PolyomavirusHuman adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
-
Respiratory Viruses, Bacteria and FungiHuman adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
-
Tropical and other Viruses, Bacteria and ParasitesAHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
The RCPAQAP Cytopathology discipline offers external quality assurance programs that encompass both gynaecological and non-gynaecological Cytopathology practice. Laboratories may enrol in any or all of the programs. Technical exercises are selected to assess common or critical features demonstrated by routine methods in the laboratory. Questionnaires on laboratory practice may also be issued.
Haematology QAP
-
Bone Marrow Morphology
-
Coagulation Factors: II, V, VII, X, XI, and XII
-
D-Dimer: Semi-quantitative
-
ESR
-
Full Blood Count
-
G6PD
-
Reticulocyte
-
Oncology Immunophenotyping
-
Paroxysmal Nocturnal Haemoglobinuria
-
Thromboelastography
-
Thromboelastometry
-
Special Haemostasis
-
Blood Borne VirusesHepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
-
Enteric Viruses and BacteriaClostridium difficile EHEC Norovirus Rotavirus
-
Human Adenovirus, Human Herpesvirus and PolyomavirusHuman adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
-
Respiratory Viruses, Bacteria and FungiHuman adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
-
Tropical and other Viruses, Bacteria and ParasitesAHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
The RCPAQAP Haematology has a comprehensive range of EQA programs covering a variety of diagnostic tests used in blood disease screening and monitoring level of blood components. Surveys are dispatched each month within the year with a wide range of samples for both routine and specialist Haematology testing. Various sample type such as lyophilised plasma and stabilised whole blood will be provided for different testing
Immunology QAP
-
Adrenal Antibodies
-
Bee Venom IgE
-
Coeliac Disease Antibodies
-
Cyclic Citrullinated Peptide
-
Drug Allergens
-
dsDNA and Associated Antibodies
-
Food Allergens
-
Fungal and Avian Antibodies
-
High Sensitivity C Reactive Protein (hsCRP)
-
Immunoglobulin
-
Immunoglobulin D
-
Immunoglobulin E
-
Immunoglobulin G Subclasses
-
Immunophenotyping
-
Inhalant Allergens
-
Liver Antibodies
-
Myositis Specific and Scleroderma Antibodies
-
Neuronal Antibodies
-
Procalcitonin
-
Rheumatoid Factor
-
Skin Antibodies
-
Thyroid antibodies
-
Tissue Autoantibodies
-
Type I Diabetes Antibodies
-
Vasculitis Antibodies
-
Blood Borne VirusesHepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
-
Enteric Viruses and BacteriaClostridium difficile EHEC Norovirus Rotavirus
-
Human Adenovirus, Human Herpesvirus and PolyomavirusHuman adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
-
Respiratory Viruses, Bacteria and FungiHuman adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
-
Tropical and other Viruses, Bacteria and ParasitesAHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
Participating laboratories may select from a group of RCPAQAP Immunology program modules that comprehensively cover the assays performed in Clinical Immunology.
All Immunology programs are made of two components:
Data Management – which includes result entry and all associated reports. A Participant Handbook and Schedules, along with all Result and Method Sheets are supplied in the RCPAQAP myQAP online customer portal.
Purchasing a Data Management enrolment is useful when the material from the Full Program can be shared with a second instrument or a satellite/branch laboratory on the same site.
Full program (material) – a complete set of material containing all the samples to be analysed for the full enrolment year is distributed to participants following enrolment.